Category: Specialty Drugs

A patient and cardiologist discuss Lipfendra cost and treatment options for high cholesterol

How to Afford Lipfendra (enlicitide), the First Cholesterol Pill of Its Kind

Lipfendra (enlicitide) is one of the most significant new heart medications in years – the first cholesterol-lowering pill of its kind. If you’ve been prescribed it, Lipfendra cost is probably on your mind. This post explains what Lipfendra is and walks through the ways to get help affording it. What Lipfendra is Lipfendra (enlicitide) is a once-daily pill made by Merck. According to Merck, the FDA approved it on July 16, 2026, as an addition to diet and exercise to reduce LDL-C – “bad” cholesterol – in adults with high cholesterol, including an inherited form called heterozygous familial hypercholesterolemia. What […]

A pharmacist helps a customer understand Foundayo cost and available savings programs

How to Afford Foundayo (orforglipron), the First GLP-1 Pill for Weight Loss

Foundayo (orforglipron) is one of the most talked-about new medications of 2026 – and if you’ve been prescribed it, Foundayo cost is probably on your mind. This post explains what Foundayo is and, more importantly, walks through the programs that can help you afford it. What Foundayo is Foundayo (orforglipron) is an oral GLP-1 receptor agonist made by Eli Lilly. According to the FDA, it was approved on April 1, 2026, for adults with obesity, or who are overweight with weight-related medical problems. What makes it notable is that it’s a pill – most GLP-1 medications for weight management are […]

A patient discusses psoriasis treatment options and psoriasis medication costs with a dermatologist

Psoriasis Action Month: Finding Help with Medication Costs

Psoriasis is a chronic autoimmune condition that speeds up the life cycle of skin cells, causing raised, scaly patches that can itch, crack, and hurt. It affects more than 7.5 million adults in the United States, according to the National Psoriasis Foundation, and for many people it’s a lifelong condition. Today’s treatments — especially the newer biologics — can clear skin dramatically, but psoriasis medication costs are a real barrier: these are often specialty medications with high price tags. This Psoriasis Action Month, we’re highlighting the treatments used and, more importantly, the programs that help make them affordable. Understanding psoriasis […]

A patient and oncologist discuss Rasonque cost and treatment support options in a supportive consultation

How to Afford Rasonque (daraxonrasib), a New Pancreatic Cancer Treatment

Rasonque (daraxonrasib) is a newly approved treatment for advanced pancreatic cancer — and for patients and families facing this diagnosis, questions about cost can add to an already overwhelming time. This post explains what Rasonque is and walks through the programs that can help with the Rasonque cost. What Rasonque is Rasonque (daraxonrasib) is a once-daily pill made by Revolution Medicines. According to the FDA, it was approved on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma — the most common form of pancreatic cancer — who have already received at least one prior treatment, or who are not […]

New Alzheimer’s Drugs Proven to Work

Alzheimer’s disease is a neurological disease that is the most common cause of dementia. It causes progressive destructive and irreversible changes in the brain. A common feature is the accumulation of a protein called amyloid-β in the form of plaques and tau tangles. Both are thought to cause brain cell death. Although among the most likely candidates, they have not yet been shown to be the cause of Alzheimer’s disease. In a blog from 2 years ago a newly approved drug for Alzheimer’s disease named aducanumab was discussed. At the time I thought the medication had not been proven to […]

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.